[1]. Weisberg E, et al. Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias. Blood. 2007 Mar 1;109(5):2112-20.
陕西西化化学工业有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!